Transdominant mutants of IκBα block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication

Journal of Virology

Volumn 70, Issue 9, 1996, Pages 5777-5785

  Beauparlant, Pierre ^a   Kwon, Hakju ^a   Clarke, Michelle ^a   Lin, Rongtuan ^a   Sonenberg, Nahum ^b   Wainberg, Mark ^a   Hiscott, John ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; ENHANCER REGION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; NONHUMAN; NORTHERN BLOTTING; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA SYNTHESIS; TRANSACTIVATION; TRANSCRIPTION INITIATION; VIROGENESIS;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAT; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; I-KAPPA B PROTEINS; KINETICS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; NUCLEIC ACID CONFORMATION; POINT MUTATION; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0029817290     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Alcami, J., T. Lain de Lera, L. Folgueira, M.-A. Pedraza, J.-M. Jacque, F. Bachelerie, A. R. Noriega, R. T. Hay, D. Harrich, R. B. Gaynor, J.-L. Virelizier, and F. Arenzana-Seisdedos. 1995. Absolute dependence on KB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J. 14:1552-1560.
2. Alkalay, I., A. Yaron, A. Hatzubai, S. Jung, A. Avraham, O. Gerlitz, I. Pashut-Lavon, and Y. Ben-Neriah. 1995. In vivo stimulation of IκB phosphorylation is not sufficient to activate NF-κB. Mol. Cell. Biol. 15:1294-1301.
3. Bachelerie, F., J. Alcami, F. Arenzana-Seisdedos, and J.-L. Virelizier. 1991. HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes. Nature (London) 350:709-712.
4. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179.
5. Bagasra, O., K. Khalili, T. Seshamma, J. Taylor, and R. Pomerantz. 1992. TAR-independent replication of human immunodeficiency virus type I in glial cells. J. Virol. 66:7522-7528.
6. Barroga, C. F., J. K. Stevenson, E. M. Schwarz, and I. M. Verma. 1995. Constitutive phosphorylation of IκBα by casein kinase II. Proc. Natl. Acad. Sci. USA 92:7637-7641.
7. Beauparlant, P. Unpublished data.
8. Beauparlant, P., R. Lin, and J. Hiscott. 1996. The role of the C-terminal domain of IκBα in protein degradation and stability. J. Biol. Chem. 271:10690-10696.
9. Beg, A. A., and S. Baldwin, Jr. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:2064-2070.
10. Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin, Jr. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 6:1899-1913.
11. Berkhout, B., A. Gatignol, A. B. Rabson, and K.-T. Jeang. 1990. TAR-independent activation of the HIV-1 LTR: evidence that Tat requires specific regions of the promoter. Cell 62:757-767.
12. Berkhout, B., and K. T. Jeang. 1992. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:139-149.
13. Biswas, D. K., C. M. Ahlers, B. J. Desube, and A. B. Pardee. 1993. Cooperative inhibition of NF-κB and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat. Proc. Natl. Acad. Sci. USA 90:11044-11048.
14. Biswas, D. K., T. R. Salas, F. Wang, C. M. Ahlers, B. J. Dezube, and A. B. Pardee. 1995. A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J. Virol. 69:7437-7444.
15. Bogerd, H., R. A. Fridell, S. Madore, and B. R. Cullen. 1995. Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 82:485-494.
16. Bours, V., P. R. Burd, K. Brown, J. Villalobos, S. Park, R.-P. Ryseck, R. Bravo, K. Kelly, and U. Siebenlist. 1992. A novel mitogen-inducible gene product related to p50/p105-NF-κB participates in transactivation through a κB site. Mol. Cell. Biol. 12:685-695.
17. Bours, V., J. Villalobos, P. R. Burd, K. Kelly, and U. Siebenlist. 1990. Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs. Nature (London) 348:76-80.
18. Brockman, J. A., D. C. Scherer, T. A. McKinsey, S. M. Hall, X. Qi, W. Y. Lee, and D. W. Ballard. 1995. Coupling of a signal response domain in IκBα to multiple pathway for NF-κB activation. Mol. Cell. Biol. 15:2809-2818.
19. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
20. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc. Natl. Acad. Sci. USA 90:2532-2536.
21. Brownell, D., N. Mittereder, and N. R. Rice. 1989. A human rel protooncogene cDNA can containing an Alu fragment as a potential coding exon. Oncogene 4:935-942.
22. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597.
23. Chiao, P. J., S. Miyamoto, and I. M. Verma. 1994 Autoregulation of 1κBα activity. Proc. Natl. Acad. Sci. USA 91:28-32.
24. Cohen, E. A., E. F. Terwillinger, J. G. Sodroski, and W. A. Haseltine. 1988. Identification of a protein encoded by the vpu gene of HIV-1. Nature (London) 334:532-534.
25. Clarke, M. Unpublished data.
26. Cullen, B. R. 1993. Does HIV-1 Tat induce a change in viral initiation rights? Cell 73:417-420.
27. Delling, U., S. Roy, M. Sumner-Smith, R. Barnett, L. Reid, C. A. Rosen, and N. Sonenberg. 1991. The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA. Proc. Natl. Acad. Sci. USA 88:6234-6238.
28. DiDonato, J. A., F. Mercurio, and M. Karin. 1995. Phosphorylation of 1κBα precedes but is not sufficient for its dissociation from NF-κB. Mol. Cell. Biol. 15:1302-1311.
29. Ernst, M. K., L. L. Dunn, and N. R. Rice. 1995. The PEST-like sequence of IκBα is responsible for inhibition of DNA binding hut not for cytoplasmic retention of c-Rel or ReIA homodimers. Mol. Cell. Biol. 15:872-882.
30. Folks, T. M., K. A. Clouse, J. Justement, A. Rabson, E. Duh, J. H. Kerhl, and A. S. Fauci. 1989. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86:2365-2368.
31. Fritz, C. C., M. L. Zapp, and M. R. Green. 1995. A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature (London) 376:530-533.
32. Garcia, J. A., F. K. Wu, R. Mitsuyasu, and R. Gaynor. 1987. Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. EMBO J. 6:3761-3770.
33. Garoufalis, E., I. Kwan, R. Lin, A. Mustafa, N. Pepin, A. Roulston, J. Lacoste, and J. Hiscott. 1994. Viral induction of the human interferon beta promoter: modulation of transcription by NF-κB/Rel proteins and interferon regulatory factors. J. Virol. 68:4707-4715.
34. Gerondakis, S., N. Morrice, I.B. Richardson, R. Wettenhall, J. Fecondo, and R. J. Grumont. 1993. The activity of a 70 kilodalton IκB molecule identical to the carboxyl terminus of the p105 NF-κB precursor is modulated by protein kinase A. Cell Growth Differ. 4:617-627.
35. Ghosh, S., A. M. Gifford, L. R. Riviere, P. Tempst, G. P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62:1019-1029.
36. Harhaj, E., J. Blaney, S. Millhouse, and S.-C. Sun. 1996. Differential effects of IκB molecules on Tat-mediated transactivation of HIV-1 LTR. Virology 216:284-287.
37. Harrich, D., J. Garcia, R. Mitsuyasu, and R. Gaynor. 1990. TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T-lymphocytes. EMBO J. 9:4417-4424.
38. Haskill, S., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, A. Sampson-Johannes, K. Mondai, P. Ralph, and A. S. Baldwin, Jr. 1991 Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281-1289.
39. Hatada, E. N., A. Nieters, F. G. Wulczyn, M. Naumann, R. Meyer, G. Nucifora, T. W. McKeithan, and C. Scheidereit. 1992. The ankyrin repeat domains of the NF-κB precursor p105 and the proto-oncogene bcl-3 act as specific inhibitors of NF-κB DNA binding. Proc. Natl. Acad. Sci. USA 89:2489-2493.
40. Hazan, U., D. Thomas, J. Alcami, F. Bachelerie, N. Israel, H. Yssel, J.-L. Virelizier, and F. Arenzana-Seisdedos. 1990. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription. Proc. Natl. Acad. Sci. USA 87:7861-7865.
41. Hiscott, J., J. Marois, J. Garoufalis, M. D'Addario, A. Roulston, I. Kwan, N. Pepin, J. Lacoste, H. Nguyen, G. Bensi, and M. Fenton. 1993. Characterization of a functional NF-κB site in the human interleukin-1β promoter: evidence for a positive autoregulatory loop. Mol. Cell. Biol. 13:6231-6240.
42. Inoue, J. I., L. D. Kerr, A. Kakizuka, and I. Verma. 1992. IκBγ, a 70 kd protein identical to the c-terminal half of pi 10 NF-κB: a new member of the IκB family. Cell 68:1109-1120.
43. Inoue, J. I., L. D. Kerr, D. Rashid, N. Davis, and H. R. Bose, Jr. 1992. Direct association of pp40/IκBβ with rel/NF-κB transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. Proc. Natl. Acad. Sci. USA 89:4333-4337.
44. Jaffray, E., K. M. Wood, and R. T. Hay. 1095. Domain organization of IκBα and the sites of interaction with NF-κB p65. Mol. Cell. Biol. 15:2166-2172.
45. Kashanchi, F., G. Piras, M. F. Radnovich, J. F. Duvall, A. Fattaey, C. M. Chiang, R. Roeder, and J. N. Brady. 1994. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature (London) 367:295-299.
46. Kieran, M., V. Blank, F. Logeat, J. Vandekerckhove, F. Lottspeich, O. Le Bail, M. B. Urban, P. Kourilsky, P. A. Baeuerle, and A. Israël. 1990. The DNA-binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007-1018.
47. Lacoste, J., M. D'Addario, A. Roulston, M. A. Wainberg, and J. Hiscott. 1990. Cell-specific differences in activation of NF-κB regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor. J. Virol. 64:4726-4734.
48. Le Bail, O., R. Schmidt-Ullrich, and A. Israël. 1993. Promoter analysis of the gene encoding the IκBα/MAD-3 inhibitor of NF-κB: positive regulation by members of the rel/NF-κB family. EMBO J. 12:5043-5049.
49. Lin, R., P. Beauparlant, C. Makris, S. Meloche, and J. Hiscott. 1996. Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol. Cell. Biol. 16:1401-1409.
50. Lin, R., D. Gewert, and J. Hiscott. 1995. Differential transcriptional activation in vitro by NF-κB/Rel proteins. J. Biol. Chem. 270:3123-3131.
51. Lin, Y.-C., K. Brown, and U. Siebenlist. 1995. Activation of NF-κB requires proteolysis of the inhibitor IκB-α: signal-induced phosphorylation of IκB-α alone does not release active NF-κB. Proc. Natl. Acad. Sci. USA 92:552-556.
52. Liou, H.-C., G. P. Nolan, S. Ghosh, T. Fujita, and D. Baltimore. 1992. The NF-κB p50 precursor, p105, contains an internal IκB-like inhibitor that preferentially inhibits p50. EMBO J. 11:3003-3009.
53. Liu, J., N. D. Perkins, R. Schmid, and G. Nabel. 1992. Specific NF-κB subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription. J. Virol. 66:3883-3887.
54. Marciniak, R. A., M. A. Garcia-Blanco, and P. A. Sharp. 1990. Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-responsive TAR element RNA. Proc. Natl. Acad. Sci. USA 87:3624-3628.
55. McElhinny, J. A., S. A. Trushin, G. D. Bren, N. Chester, and C. V. Paya. 1996. Casein kinase II phosphorylates IκBα at S-283, S-289, S-293, and T-291 and is required for its degradation. Mol. Cell. Biol. 16:899-906.
56. Mercurio, F., J. A. DiDonato, C. Roselte, and M. Karin. 1993. p105 and p98 precursor proteins play an active role in NF-κB mediated signal transduction. Genes Dev. 7:705-718.
57. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326:711-713.
58. Naumann, M., A. Nieters, E. N. Hatada. and C. Scheidereil. 1993 NF-κB precursor p100 inhibits nuclear translocation and DNA binding of NF-κB/rel factors. Oncogene 8:2275-2281.
59. Neri, A., C.-C. Chang, L. Lombardi, M. Salina, P. Corradini, A. T. Maiolo, R. S. K. Chaganti, and R. Dalla-Favera. 1991. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell 67:1075-1087.
60. Nolan, G. P., S. Ghosh, H.-C. Liou, P. Tempst, and D. Baltimore. 1991. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64:961-969.
61. Pepin, N., A. Roulston, J. Lacoste, R. Lin, and J. Hiscott. 1994. Subcellular redistribution of HTLV-1-Tax protein by NF-κB/Rel transcription factors. Virology 204:706-716.
62. Perkins, N. D., R. M. Schmid, C. S. Duckett, K. Leung, N. R. Rice, and G. J. Nabel. 1992. Distinct combinations of NF-κB subunits determine the specificity of transcriptional activation. Proc. Natl. Acad. Sci. USA 89:1529-1533.
63. Rooke, R., R. Tremblay, and M. A. Wainberg. 1990. AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells. Virology 176:205-215.
64. Roulston, A., P. Beauparlant, N. R. Rice, and J. Hiscott. 1993. Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-κB/rel DNA-binding activities in myelomonoblastic cells. J. Virol. 67:5235-5246.
65. Roulston, A., M. D'Addario, F. Boulerice, S. Caplan, M. Wainberg, and J. Hiscott. 1992. Induction of monocytic differentiation and NF-κB-like activities by human immunodeficiency virus-1 infection of human myclomonoblastic cells. J. Exp. Med. 175:751-763.
66. Roulston, A., R. Lin, P. Beauparlant, M. A. Wainherg, and J. Hiscott. 1995. Regulation of human immunodeficiency virus type I and cytokine gene expression in myeloid cells by NF-κB/Rel transcription factors. Microbiol. Rev. 59:481-505.
67. Roy, S., U. Delling, C.-H. Chen, C. A. Rosen, and N. Sonenberg. 1990. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes Dev. 4:1365-1373.
68. Roy, S., N. T. Parkin, C. Rosen, J. Itovitch, and N. Sonenberg. 1990. Structural requirement for trans-activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by Tat: importance of base pairing, loop sequence, and bulge in the Tat-responsive sequence. J. Virol. 64:1402-1406.
69. Ruben, S. M., P. J. Dillon, R. Schreck, T. Henkel, C. H. Chen, M. Maher, P. A. Baeuerle, and C. A. Rosen. 1991. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-κB. Science 251:1490-1493.
70. Ruben, S. M., J. F. Klement, T. A. Coleman, M. Maher, C.-H. Chen, and C. A. Rosen. 1992. I-rel: a novel rel-related protein that inhibits NF-κB transcriptional activity. Genes Dev. 6:745-760,
71. Ryseck, R.-P., P. Bull, M. Takamiya, V. Bours, U. Siebenlist, P. Dobrzanski, and R. Bravo. 1992. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12:674-684.
72. Scherer, D. C., J. A. Brockman, Z. Chen, T. Maniatis, and D. W. Ballard. 1995. Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92:11259-11263.
73. Schmid, R. M., N. D. Perkins, C. S. Duckett, P. C. Andrews, and G. J. Nabel. 1991. Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65. Nature (London) 352:733-736.
74. Selby, M. J., E. S. Bain, P. A. Luciw, and B. M. Peterlin. 1989. Structure, sequence, and position of the stem-loop in TAR determine transcriptional elongation by Tat through the HIV-1 long terminal repeat. Genes Dev. 3:547-558.
75. Sheline, C. T., L. H. Milocco, and K. A. Jones. 1991. Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. Genes Dev. 5:2508-2520.
76. Stutz, F., M. Neville, and M. Rosbash. 1995. Identification of a novel poreassociated protein as a functional target of the HIV-1 Rev protein in yeast. Cell 82:495-506.
77. Sun, S.-C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259:1912-1915.
78. Taylor, J. P., R. Pomerantz, O. Bagasra, M. Chowdhury, J. Rappaport, K. Khalili, and S. Amini. 1992. TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation. EMBO J. 11:3395-3403.
79. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573-582.
80. Traenckner, E. B.-M., S. Wilk, and P. A. Baeuerle. 1994. A proteasome inhibitor prevents activation of NF-KB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 13:5433-5441.
81. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. V. Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
82. Westendorp, M. O., V. A. Shatrov, K. Schulze-Osthoff, R. Frank, M. Kraft, M. Los, P. H. Krammer, W. Drige, and V. Lehnann. 1995. HIV-1 Tat potentiates TNF-induccd NF-κB activation and cytotoxicity by altering the cellular redox state. EMBO J. 14:546-554.
83. Westendorp, M. O., M.-L. Weber, R. W. Frank, and P. H. Krammer. 1994. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J. Virol. 68:4177-4185.
84. Wu, B.-Y., C. Woffendin, C. S. Duckett, T. Ohno, and G. J. Nabel. 1995. Regulation of human retroviral latency by the NF-κB/IκB family: inhibition of human immunodeficiency virus replication by IκB through a Rev-dependent mechanism. Proc. Natl. Acad. Sci. USA 92:1480-1484.